IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GIUSTINA, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.297
EU - Europa 6.170
AS - Asia 3.328
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 18
SA - Sud America 10
AF - Africa 8
Totale 27.851
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.252
UA - Ucraina 2.552
CN - Cina 2.305
DE - Germania 936
PL - Polonia 742
HK - Hong Kong 660
FI - Finlandia 506
FR - Francia 375
IE - Irlanda 363
GB - Regno Unito 299
IT - Italia 275
IN - India 151
SG - Singapore 88
CA - Canada 44
TR - Turchia 43
RU - Federazione Russa 35
SE - Svezia 33
VN - Vietnam 28
BE - Belgio 25
IR - Iran 25
EU - Europa 20
AU - Australia 18
NL - Olanda 12
JP - Giappone 7
BR - Brasile 6
SA - Arabia Saudita 5
MU - Mauritius 4
RO - Romania 4
ES - Italia 3
TW - Taiwan 3
BD - Bangladesh 2
CL - Cile 2
CM - Camerun 2
DK - Danimarca 2
EC - Ecuador 2
ID - Indonesia 2
MA - Marocco 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MX - Messico 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 27.851
Salva come PNG Salva come JPEG
Città #
Fairfield 3.202
Woodbridge 2.438
Jacksonville 1.734
Houston 1.732
Ashburn 1.424
Cambridge 1.301
Ann Arbor 1.272
Seattle 1.209
Wilmington 1.105
Warsaw 741
Princeton 687
Hong Kong 652
Nanjing 635
Chandler 515
Dublin 363
Beijing 319
Nanchang 256
New York 219
Helsinki 182
Des Moines 181
Shenyang 163
Changsha 135
San Diego 130
Hebei 126
Jiaxing 109
Tianjin 103
Milan 89
Kunming 69
Jinan 68
Brescia 54
Dearborn 49
Verona 47
Hangzhou 46
Shanghai 41
Lancaster 40
San Mateo 37
Lanzhou 36
Kocaeli 35
Haikou 32
Ningbo 29
Dong Ket 28
Leawood 28
Toronto 28
San Francisco 27
Boardman 25
Los Angeles 25
Zhengzhou 25
Brussels 24
Augusta 22
Taizhou 22
Guangzhou 20
Ardabil 18
Changchun 16
London 16
Washington 16
Orange 14
Taiyuan 12
Monmouth Junction 11
Norwalk 11
Redwood City 11
Fuzhou 9
Mumbai 9
Ottawa 9
Cassina de' Pecchi 8
Kilburn 8
Melbourne 8
Tokyo 7
Greifswald 6
Nürnberg 6
Pune 6
Canberra 5
Central 5
New Bedfont 5
Phoenix 5
Auburn Hills 4
Bangalore 4
Falkenstein 4
Hefei 4
Riyadh 4
Sydney 4
Ariano nel Polesine 3
Bergamo 3
Bologna 3
Brockton 3
Cleveland 3
Falls Church 3
Hanover 3
Hendon 3
Islington 3
Napoli 3
Sabz 3
São Paulo 3
Bellante 2
Capo Rizzuto 2
Castegnato 2
Charlotte 2
Chicago 2
Chiswick 2
Clearwater 2
Como 2
Totale 22.176
Salva come PNG Salva come JPEG
Nome #
Elevated intraocular pressure in patients with acromegaly 264
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 242
Ghrelin regulates proliferation and differentiation of osteoblastic cells 196
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. 193
Guidelines for acromegaly management. 180
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 144
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 142
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 141
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 140
Growth hormone deficiency in treated acromegaly 131
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 129
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 129
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 128
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. 126
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 124
Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells 120
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 119
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 116
The management of the patient with acromegaly and headache: a still open clinical challenge. 115
Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. 114
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 113
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 113
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 112
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 112
Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. 111
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 110
Pituitary testing: a reappraisal. 109
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. 108
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. 108
A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients. 108
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 108
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 108
Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? 107
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 107
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 107
Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. 105
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. 103
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 103
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals 103
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 103
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study. 102
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients. 102
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. 102
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 102
A consensus on criteria for cure of acromegaly. 101
Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells 101
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. 100
Guidelines for acromegaly management: an update. 99
New oral anticoagulants and pituitary apoplexy 99
High prevalence of radiological vertebral fractures in HIV-infected males 98
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 98
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. 98
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 97
Development of isolated ACTH deficiency in a man with type I diabetes mellitus. 97
Influence of diabetes mellitus on vertebral fractures in men with acromegaly. 96
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 96
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 95
Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. 95
Glucocorticoid inhibition of growth in rats: partial reversal with the full length ghrelin analog BIM-28125 94
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. 94
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. 94
Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone. 94
Octreotide for acromegaly treatment: a reappraisal. 94
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 94
TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS. 94
TREATMENT OF HYPOTHYROIDISM:ALL THAT GLITTERS IS GOLD? 94
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: in vitro studies. 93
Effects of metoclopramide on the growth hormone response to galanin in normal man. 93
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 93
Prevalence of vertebral fractures in men with acromegaly 92
Pituitary gland: Medical therapy for acromegaly: can we predict response? 92
Growth hormone in glucocorticoid-induced osteoporosis. 92
Treatment of Cushing disease: overview and recent findings. 92
Glucocorticoids and the regulation of growth hormone secretion. 92
Cardiovascular risk in aging and obesity: is there a role for GH. 92
New understanding and treatments for osteoporosis. 91
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. 91
CORTISOL AND THE MUSCLE-BONE AXIS:RESPONSE TO COMMENTS BY MOLFINO ET AL. 91
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 90
Does growth hormone replacement therapy improve cardiac function? 90
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. 90
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 90
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. 90
Effect of age on beta-cell response to exogenous glucagon in man. 90
Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection. 90
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 90
SAGIT(®): clinician-reported outcome instrument for managing acromegaly in clinical practice-development and results from a pilot study 90
Vertebral fractures in males with prolactinoma. 90
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. 89
Growth hormone deficiency in the adult. 89
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 89
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 89
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 89
A consensus on criteria for cure acromegaly 89
Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. 89
Inhibitory effects of galanin on growth hormone (GH) release in cultured GH-secreting adenoma cells: comparative study with octreotide, GH-releasing hormone, and thyrotropin-releasing hormone. 89
Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly. 89
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 89
Current management practices for acromegaly: an international survey. 89
Long-term Picotamide, a dual thromboxane inhibitor, decreases both the urinary excretion of thromboxane B2 (TXB2) and albumin in patients with type 2 diabetes. 88
Totale 10.752
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.993
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.080 0 0 0 0 0 0 0 0 0 0 1.106 974
2019/20209.203 1.438 302 354 1.247 568 951 805 1.026 685 1.016 292 519
2020/20215.224 88 619 123 606 225 618 209 678 727 517 641 173
2021/20222.420 136 491 35 108 12 147 98 158 116 357 209 553
2022/20231.772 386 48 10 94 150 567 2 143 234 15 58 65
2023/20241.617 107 38 92 158 91 287 110 42 668 24 0 0
Totale 28.132